Obstetrics/Gynecology
RSSArticles
-
Telemedicine May Offer Access Option for Abortion
The TelAbortion study is designed to evaluate the use of telemedicine in providing medication abortion to women who have difficulty accessing abortion clinics.
-
Pharmacist-Prescribed Contraception Effective in Oregon
Study findings indicate that in the first two years after the Oregon law went into effect in 2016, pharmacist-prescribed contraception prevented more than 50 unintended pregnancies and saved an estimated $1.6 million in associated taxpayer costs.
-
Help Us Help You
Take our annual reader survey and tell us how we can better serve you.
-
New Progestin-Only Pill Receives FDA Approval
Women who are seeking an estrogen-free form of contraception now have a new option: Slynd, a drospirenone progestin-only pill. The pill is scheduled for release in fall 2019.
-
Counsel Teens on Dual Use of Condoms with LARC Methods
While more adolescents are choosing long-acting reversible contraceptive methods, they may not be implementing dual use of condoms to protect themselves from sexually transmitted infections.
-
Help Us Help You
-
Thank You, Molly Brewer; Welcome Melissa Moffitt
-
Progesterone: Not a Treatment for Threatened Abortion
Investigators of this well-designed, randomized, controlled trial conclusively demonstrated that progesterone supplementation does not reduce the risk of early pregnancy loss in women who experience first trimester bleeding.
-
Should Antibiotic Prophylaxis Be Used for Surgical Treatment of Early Pregnancy Loss?
In this randomized, controlled trial of more than 3,000 women in developing countries with incomplete or missed abortion at less than 22 weeks’ gestation, antibiotic prophylaxis prior to uterine evacuation reduced infection rates when a strict definition for pelvic infection was used, but not when a more expanded definition was used.
-
Behavioral Interventions for Menopausal-Related Insomnia Improve Depression
In a randomized, controlled trial comparing the behavioral interventions cognitive behavioral therapy for insomnia (CBTI) and sleep reduction therapy (SRT) to a control intervention of sleep hygiene education, investigators found CBTI and SRT therapy improved insomnia and depressive symptoms in postmenopausal women with menopausal-related insomnia.